flucelvax tetra
seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripp, inimene - gripi, inaktiveeritud, kokkuklapitavad viirus või pinna antigeen - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra tuleb kasutada vastavalt ametlikele soovitustele.
regiocit hemofiltratsioonilahus
baxter holding b.v. - naatriumtsitraat+naatriumkloriid - hemofiltratsioonilahus - 5,29g+5,03g 1000ml 5000ml 2tk
lucentis
novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - oftalmoloogilised vahendid - lucentis on näidustatud täiskasvanute jaoks:ravi neovascular (märg) vanusega seotud makuladegeneratsiooni (amd)raviks nägemispuudega tõttu choroidal neovascularisation (cnv)ravi nägemispuudega tõttu diabeediga macular turse (dme)ravi nägemispuudega tõttu macular turse teisejärguline võrkkesta veeni oklusioon (branch rvo-või kesk-rvo).
braunovidon salv
b. braun melsungen ag - joodpovidoon - salv - 100mg 1g 20g 1tk; 100mg 1g 100g 1tk
jetrea
inceptua ab - ocriplasmin - võrkkesta haigused - oftalmoloogilised vahendid - jetrea on näidustatud täiskasvanutel ravi vitreomakulaarse traktsiooni ravimiseks, kui kaasub makula läbimõõt on väiksem või võrdne 400 mikronit, sealhulgas.
fiprotec täpilahus
beaphar b.v. - fiproniil - täpilahus - 50mg 0.5ml 0.5ml 9tk; 50mg 0.5ml 0.5ml 12tk; 50mg 0.5ml 0.5ml 6tk; 50mg 0.5ml 0.5ml 3tk; 50mg 0.5ml 0.5ml 1tk
fleanil täpilahus
norbrook laboratories limited - fiproniil - täpilahus - 50mg 0.5ml 0.5ml 2tk; 50mg 0.5ml 0.5ml 4tk; 50mg 0.5ml 0.5ml 12tk; 50mg 0.5ml 0.5ml 6tk; 50mg 0.5ml 0.5ml 150tk; 50mg 0.5ml 0.5ml 60tk; 50mg 0.5ml 0.5ml 8tk; 50mg 0.5ml 0.5ml 3tk; 50mg 0.5ml 0.5ml 90tk; 50mg 0.5ml 0.5ml 120tk; 50mg 0.5ml 0.5ml 1tk
pestigon täpilahus
norbrook laboratories (ireland) limited - fiproniil - täpilahus - 50mg 0.5ml 0.5ml 60tk; 50mg 0.5ml 0.5ml 2tk; 50mg 0.5ml 0.5ml 8tk; 50mg 0.5ml 0.5ml 90tk; 50mg 0.5ml 0.5ml 12tk; 50mg 0.5ml 0.5ml 150tk; 50mg 0.5ml 0.5ml 6tk; 50mg 0.5ml 0.5ml 24tk; 50mg 0.5ml 0.5ml 3tk; 50mg 0.5ml 0.5ml 4tk
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloogilised vahendid - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).